CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 62 enrolled
Drug / intervention
Cardiobanddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01841554
NCT01841554N/ACompleted

Cardioband Adjustable Annuloplasty System For Transcatheter Repair of Mitral Valve Regurgitation

Edwards Lifesciences·interventional·Posted Apr 26, 2013·Updated Nov 30, 2020

In Brief

A clinical study evaluating Cardioband for Mitral Regurgitation. Completed, enrolled 62 participants across 11 sites in 6 countries.

Detailed Summary

To evaluate the performance and safety of the Cardioband Adjustable Annuloplasty System for repair of functional mitral regurgitation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance, Germany, Israel, Italy, Netherlands, Switzerland
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 26, 2013
Enrollment StartSep 1, 2011
Primary CompletionAug 1, 2016
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 13.2 years ago

Interventions

Cardiobanddevice